Quick Takeaways
- This page summarizes Barbara Weber's Form 4 filing for Tango Therapeutics, Inc. (TNGX).
- 2 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 06 Feb 2025, 20:02.
Barbara Weber - 04 Feb 2025 Form 4 Insider Report for Tango Therapeutics, Inc. (TNGX)
- Signature
- /s/ Douglas Barry, attorney-in-fact
- Issuer symbol
- TNGX
- Transactions as of
- 04 Feb 2025
- Net transactions value
- -$57,710
- Form type
- 4
- Filing time
- 06 Feb 2025, 20:02:12 UTC
- Previous filing
- 05 Feb 2025
- Next filing
- 04 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Barbara Weber filed Form 4 for Tango Therapeutics, Inc. (TNGX) on 06 Feb 2025."
What Changed
- Previous filing in this sequence was filed on 05 Feb 2025.
- Current net transaction value: -$57,710.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TNGX | Common Stock | Sale | $29,217 | -9,778 | -0.6% | $2.99 | 1,631,264 | 04 Feb 2025 | Direct | F1, F2 |
| transaction | TNGX | Common Stock | Sale | $28,494 | -9,013 | -0.55% | $3.16 | 1,622,251 | 05 Feb 2025 | Direct | F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. |
| F2 | Represents the weighted average sales price per share. The shares sold at prices ranging from $2.86 to $3.07 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| F3 | Represents the weighted average sales price per share. The shares sold at prices ranging from $3.00 to $3.245 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |